Ginkgo Bioworks SPAC Investors Sue In Del. After Stock Drop
Investors in the blank check company that took biotech firm Ginkgo Bioworks Inc. public in September 2021 have sued the venture's founders and insiders for unjust enrichment and fiduciary breaches in...To view the full article, register now.
Already a subscriber? Click here to view full article